How does trihexyphenidyl work in the body?
Trihexyphenidyl is an anticholinergic (antimuscarinic) medication. It blocks muscarinic acetylcholine receptors, which reduces cholinergic (acetylcholine-related) signaling in the brain and other tissues [1]. This shifts the balance between acetylcholine and dopamine activity in motor pathways, helping lessen symptoms that are driven by cholinergic predominance—especially involuntary muscle activity and stiffness.
What does it treat, and why does blocking muscarinic receptors help?
Trihexyphenidyl is used to treat extrapyramidal symptoms such as Parkinsonian tremor, rigidity, and drug-induced movement disorders. These conditions involve disrupted motor circuit signaling where acetylcholine activity can become relatively overactive. By blocking muscarinic receptors, trihexyphenidyl dampens that overactive cholinergic influence, which can improve tremor and rigidity [1].
Does it act only in Parkinson’s disease?
No. Because its main pharmacologic action is muscarinic blockade, it can also be used for medication-induced extrapyramidal symptoms (for example, from antipsychotic drugs) where cholinergic/dopaminergic balance is disrupted [1]. The symptom improvements come from the same general mechanism: reducing acetylcholine’s muscarinic effects.
Key mechanism-of-action takeaways (quick reference)
Trihexyphenidyl works by antagonizing muscarinic acetylcholine receptors (anticholinergic action), which reduces cholinergic signaling and helps restore functional balance in motor pathways affected in Parkinsonism and extrapyramidal symptoms [1].
What side effects usually connect to its mechanism?
Because it blocks muscarinic receptors, trihexyphenidyl commonly causes anticholinergic effects such as dry mouth, blurred vision, constipation, urinary retention, and cognitive changes. These are direct consequences of reduced muscarinic (acetylcholine) signaling in peripheral tissues and the brain [1].
Are there limitations to the mechanism?
Trihexyphenidyl mainly targets symptoms tied to cholinergic signaling imbalance (like tremor/rigidity) rather than replacing the underlying dopamine loss in Parkinson’s disease. In practice, it is often used to manage specific motor symptoms or extrapyramidal side effects, depending on the patient’s regimen [1].
Sources:
[1] https://www.drugs.com/mtm/trihexyphenidyl.html